Epigenetic drug discovery and tools
 

Management and Board

Management

 

    Barrie Ward   Executive Chairman
    Will West   Chief Executive
    Tim Fell  Chief Operating Officer
    David Knowles  Chief Scientific Officer
    Nessa Carey  Scientific Director
    Neil Pegg Director of Discovery Research
    Jonathan Best Programme Manager
    Dev Crease  Patent Counsel
    Richard Brooks Finance Director
    Thea Stanway  Finance Officer

  

Board

 

    Barrie Ward  Executive Chairman
    Will West  Executive Director
    Tim Fell Executive Director
    David Knowles  Executive Director
    Gerald Chan Non-Executive Director
    Sue Foden Non-Executive Director
    Dan Roach Non-Executive Director
    David Secher Non-Executive Director
    Azim Surani Board Observer
 

 

Azim Surani

Azim SuraniAzim Surani FRS is the Marshall-Walton Professor of Physiology of Reproduction (since 1992), a senior Group Leader, Wellcome Trust Cancer Research UK Institute of Developmental Biology & Cancer Research and a Professorial Fellow at King's College (since 1993).

 

Professor Surani is recognised as a world leader in his field of epigenetics. He is a founder member of the Stem Cell Consortium, University of Cambridge and is a member of several stem cell initiatives including the Royal Society Advisory Group on Stem Cells and the DFG panel for the Stem Cell Initiative in Germany.

 

Professor Surani has been the recipient of multiple awards, most recently the 36th Annual Lewis S. Rosenstiel Award for 2007 for Distinguished Work in Basic Medical Science. Other accolades include Fellow of the Royal Society (1990), the Cambridge Philosophical Society William Bate Hardy Prize (1991), Associate Fellow of the Third World Academy of Sciences (1992), BBSRC Individual Merit Awards: (1986 & 1992), National Institute of Child Health and Wellcome-Burroughs Research Pioneer Award (1999), Doctor of Science honoris causa, University of Uppsala, Sweden (1994), Fellow of the Academy of Medical Sciences (2001) and The Royal Society Gabor Medal (2001). Professor Surani has also been made an elected member of the European Molecular Biology Organisation (1993), the Academia Europaea (1994) and Menten Visiting Professor of Pathology, School of Medicine, Department of Pathology, University of Pittsburgh, USA (1990). He is also a member of the Scientific Advisory Board, for Paradigm Therapeutics. Professor Surani was also a co-author on the key patent Production of Antibodies from Transgenic Animals (WO90/04036 Bruggemann, Surani and Neuberger).